Genetic infertility

Genetic infertility (Orphanet code 275742) is a broad category encompassing a heterogeneous group of rare genetic conditions in which inherited genetic abnormalities lead to impaired fertility or complete inability to conceive. These conditions affect the reproductive system in both males and females and can result from chromosomal abnormalities (such as Klinefelter syndrome in males or Turner syndrome in females), single-gene mutations, or complex genetic rearrangements. In males, genetic infertility may manifest as azoospermia (absence of sperm), severe oligozoospermia (very low sperm count), or abnormal sperm morphology and motility, often involving disruption of spermatogenesis. In females, genetic causes of infertility can include premature ovarian insufficiency, disorders of sex development, uterine anomalies, or disrupted oogenesis. The underlying genetic mechanisms are highly diverse and may involve mutations in genes critical for gonadal development, hormone signaling pathways (such as the hypothalamic-pituitary-gonadal axis), meiotic processes, or gamete maturation. Chromosomal causes include sex chromosome aneuploidies, Y-chromosome microdeletions, and balanced translocations. Monogenic causes include mutations in genes such as CFTR (associated with congenital bilateral absence of the vas deferens), FSHR, LHCGR, NR5A1, TEX11, SYCP3, and many others. Because genetic infertility is an umbrella classification, the specific clinical presentation, severity, and prognosis vary widely depending on the underlying genetic etiology. Treatment options depend on the specific genetic diagnosis and may include assisted reproductive technologies (ART) such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), or the use of donor gametes. Hormonal therapies may be beneficial in some cases, particularly where hypogonadotropic hypogonadism is the underlying cause. Genetic counseling is an essential component of management, as some forms of genetic infertility carry implications for offspring health or may be transmissible to future generations through ART. Advances in genomic testing, including whole-exome and whole-genome sequencing, are increasingly enabling precise molecular diagnoses for previously unexplained infertility.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Genetic infertility